Skip to main content

Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Veradigm Inc. (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions announced today that Dr. Yin Ho, Veradigm Interim Chief Executive Officer and board member, Lee Westerfield, Interim Chief Financial Officer, and Will Manidis Co-Founder of ScienceIO will participate in a fireside chat at the KeyBanc Capital Markets Life Science & MedTech Investor Forum on Tuesday, March 19th, 2024 at 12:00 PM EDT.

The webcast will be available in the investor section of the company's website at investor.veradigm.com, with an archived version accessible later that same day.

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.

© 2024 Veradigm Inc. and/or its affiliates. All rights reserved.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  255.11
-0.25 (-0.10%)
AAPL  273.27
+0.10 (0.04%)
AMD  305.13
+1.68 (0.55%)
BAC  52.52
-0.59 (-1.12%)
GOOG  338.53
+0.80 (0.24%)
META  658.60
-16.12 (-2.39%)
MSFT  414.73
-18.19 (-4.20%)
NVDA  199.09
-3.41 (-1.68%)
ORCL  176.23
-11.27 (-6.01%)
TSLA  374.40
-13.11 (-3.38%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.